South Korea
· Delayed Price · Currency is KRW Xcell Therapeutics Statistics
Total Valuation
KOSDAQ:373110 has a market cap or net worth of KRW 42.33 billion. The enterprise value is 39.23 billion.
| Market Cap | 42.33B |
| Enterprise Value | 39.23B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:373110 has 10.94 million shares outstanding. The number of shares has increased by 13.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 10.94M |
| Shares Change (YoY) | +13.14% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 17.72% |
| Owned by Institutions (%) | 0.08% |
| Float | 7.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.88 |
| PB Ratio | 4.64 |
| P/TBV Ratio | 4.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.11 |
| EV / Sales | 20.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.32 |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.63.
| Current Ratio | 2.14 |
| Quick Ratio | 1.90 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.77 |
| Interest Coverage | -2,119.47 |
Financial Efficiency
Return on equity (ROE) is -165.90% and return on invested capital (ROIC) is -49.18%.
| Return on Equity (ROE) | -165.90% |
| Return on Assets (ROA) | -42.63% |
| Return on Invested Capital (ROIC) | -49.18% |
| Return on Capital Employed (ROCE) | -77.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.14 |
| Inventory Turnover | 4.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 4,161.70 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.21 |
| Average Volume (20 Days) | 287,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:373110 had revenue of KRW 1.93 billion and -9.54 billion in losses. Loss per share was -954.00.
| Revenue | 1.93B |
| Gross Profit | -1.40B |
| Operating Income | -9.33B |
| Pretax Income | -9.54B |
| Net Income | -9.54B |
| EBITDA | -7.68B |
| EBIT | -9.33B |
| Loss Per Share | -954.00 |
Balance Sheet
The company has 8.80 billion in cash and 5.70 billion in debt, giving a net cash position of 3.10 billion or 283.43 per share.
| Cash & Cash Equivalents | 8.80B |
| Total Debt | 5.70B |
| Net Cash | 3.10B |
| Net Cash Per Share | 283.43 |
| Equity (Book Value) | 9.12B |
| Book Value Per Share | 835.38 |
| Working Capital | 5.61B |
Cash Flow
In the last 12 months, operating cash flow was -7.00 billion and capital expenditures -382.69 million, giving a free cash flow of -7.38 billion.
| Operating Cash Flow | -7.00B |
| Capital Expenditures | -382.69M |
| Free Cash Flow | -7.38B |
| FCF Per Share | -674.60 |
Margins
| Gross Margin | -72.30% |
| Operating Margin | -482.33% |
| Pretax Margin | -493.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:373110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.14% |
| Shareholder Yield | -13.14% |
| Earnings Yield | -22.54% |
| FCF Yield | -17.43% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:373110 has an Altman Z-Score of -0.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.94 |
| Piotroski F-Score | n/a |